Conference Coverage

Treatment With t-PA Reduces Mortality After Intraventricular Hemorrhage


 

References

“Our results suggest that physicians should begin to think about routinely using [t-PA] for stable hemorrhagic stroke patients,” Dr. Hanley concluded.

Pages

Recommended Reading

Sickle cell anemia: Stroke screening still underused
MDedge Neurology
USPSTF updates guideline for preventive aspirin therapy
MDedge Neurology
AAN updates botulinum toxin guidelines for most established uses
MDedge Neurology
Endovascular thrombectomy procedure volume for stroke may not affect outcomes
MDedge Neurology
Medical Treatment May Be Safer Than Invasive Treatment for Arteriovenous Malformation
MDedge Neurology
Late-Life Pregnancy Increases Risk of Hemorrhagic Stroke
MDedge Neurology
Can Natalizumab Improve Stroke Recovery?
MDedge Neurology
Prevent Stroke, Prevent Dementia?
MDedge Neurology
Cardiovascular Health May Prevent Cognitive Decline
MDedge Neurology
Idarucizumab May Reverse Dabigatran Anticoagulation in Intracranial Hemorrhage
MDedge Neurology

Related Articles